Back to results
US 2022/0090019 A1Published application
Stromal stem cells
AssigneeOrbsen Therapeutics Limited
InventorStephen Joseph Elliman
Life of this patent
Estimating the term…
Abstract
Stromal stem cells are prospectively isolated from human bone marrow then expanded into clonal populations and cultured and used, the isolation being on the basis of expression of a cell surface marker, wherein the cell surface marker binds an antibody and wherein said antibody cross reacts with a cell surface marker found on mouse stromal stem cells or rat stromal stem cells, and optionally also on a cell of at least one other mammalian species selected from mouse, rat, horse, rabbit and pig cells. Useful stromal stem cell populations are positive for SDC2.
Claims13
A composition comprising:
- (i) a population of mammalian stromal stem cells, wherein 30% or more of the cells are positive for SDC2;
- and (ii) a cryopreservant, wherein the population of mammalian stromal stem cells exhibits 1000-fold or more colony forming units compared with native pre-sorted mononuclear cells.
Dependencies are inferred from the claim text.